Twist Bioscience Corp(TWST)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TWST Twist Bioscience Corp

盘前交易 10-20 07:20:42 EDT

139.77

+7.02

+5.29%

盘前136.10

-3.67-2.63%

07:20 EDT

最高141.80	最低133.72	成交量159.25万
今开136.99	昨收132.75	日振幅6.09%
总市值92.01亿	流通市值90.37亿	总股本6,583万
成交额2.21亿	换手率2.46%	流通股本6,465万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TWST","market":"US","secType":"STK","nameCN":"Twist Bioscience Corp","latestPrice":139.77,"timestamp":1792440000000,"preClose":132.75,"halted":0,"volume":1592539,"hourTrading":{"tag":"盘前","latestPrice":136.1,"preClose":139.77,"latestTime":"07:20 EDT","volume":3822,"amount":523511.99082,"timestamp":1792495204806,"change":-3.67,"changeRate":-0.026257,"amplitude":0.038492},"delay":0,"changeRate":0.052881355932203465,"floatShares":64654475,"shares":65832424,"eps":-2.229262,"marketStatus":"盘前交易","change":7.02,"latestTime":"10-20 07:20:42 EDT","open":136.99,"high":141.8,"low":133.72,"amount":221175033.24878,"amplitude":0.060866,"askPrice":137.45,"askSize":200,"bidPrice":135,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.229262,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792503000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1540958400000,"exchange":"NASDAQ","adjPreClose":139.77,"preHourTrading":{"tag":"盘前","latestPrice":136.1,"preClose":139.77,"latestTime":"07:20 EDT","volume":3822,"amount":523511.99082,"timestamp":1792495204806,"change":-3.67,"changeRate":-0.026257,"amplitude":0.038492},"postHourTrading":{"tag":"盘后","latestPrice":138.77,"preClose":139.77,"latestTime":"19:30 EDT","volume":9485,"amount":1324224.104,"timestamp":1792452605297,"change":-1,"changeRate":-0.007155,"amplitude":0.007155},"volumeRatio":0.6280648221216332,"impliedVol":1.0309,"impliedVolPercentile":0.98},"requestUrl":"/m/hq/s/TWST","defaultTab":"news","newsList":[{"id":"1167324395","title":"异动解读｜Twist Bioscience Corp盘中上涨5.09%，持股变动披露带动关注升温","url":"https://stock-news.laohu8.com/highlight/detail?id=1167324395","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167324395?lang=zh_cn&edition=full","pubTime":"2026-10-19 21:40","pubTimestamp":1792417207,"startTime":"0","endTime":"0","summary":"10月19日，Twist Bioscience Corp盘中上涨5.09%，报139.055美元/股，成交额1281.7万美元。消息面上，公司出现持股变动声明，涉及Laponis Adam，成为当日股价异动的公开事件催化。从背景看，公司此前接连遭遇投行启动覆盖但仅给出中性或持有评级，Jefferies曾给出150美元目标价，UBS给出144美元目标价，市场对其合成DNA及AIDD验证服务业务的短期估值分歧仍在。此次持股变动披露后，市场关注度有所回升。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience盘中上涨，持股变动披露引关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100312530","title":"异动解读｜Twist Bioscience Corp盘中下跌5.27%，投行中性定价后估值分歧延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1100312530","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100312530?lang=zh_cn&edition=full","pubTime":"2026-10-16 21:46","pubTimestamp":1792158405,"startTime":"0","endTime":"0","summary":"10月16日，Twist Bioscience Corp盘中下跌5.27%，报136.87美元/股，成交额1990.35万美元。消息面上，市场仍在消化投行近期启动覆盖但仅给出中性评级的影响，偏中性的目标价未能提供新的上行催化。此前Jefferies给予该股持有评级及150美元目标价，基本贴近当时股价；更早前，UBS也给予中性评级及144美元目标价。连续偏中性的定价使市场对其合成DNA及AIDD验证服务赛道的短期估值分歧延续，股价近日持续承压。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Twist Bioscience盘中下跌，投行中性定价难撑估值","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105831666","title":"异动解读｜Twist Bioscience盘中下跌9.74%，投行中性定价后估值分歧延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1105831666","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105831666?lang=zh_cn&edition=full","pubTime":"2026-10-15 21:42","pubTimestamp":1792071743,"startTime":"0","endTime":"0","summary":"10月15日，Twist Bioscience盘中下跌9.74%，报132.19美元/股，成交额6280.79万美元。消息面上，市场仍在消化投行近期启动覆盖但仅给出持有评级的影响，偏中性的定价未能提供新的上行催化。此前Jefferies给予Twist Bioscience持有评级及150美元目标价，基本贴近当时股价；随后公司股价已连续回落。结合其所处合成DNA及AIDD验证服务赛道，短期估值分歧仍在延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bio大跌，投行中性定价难撑估值","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170311451","title":"异动解读｜Twist Bioscience Corp盘前下跌5.14%，投行中性定价后估值分歧延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1170311451","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170311451?lang=zh_cn&edition=full","pubTime":"2026-10-15 19:15","pubTimestamp":1792062926,"startTime":"0","endTime":"0","summary":"10月15日，Twist Bioscience Corp盘前下跌5.14%，报140.54美元/股，成交额144.02万美元。消息面上，市场仍在消化投行近期启动覆盖但仅给出持有评级的影响。Jefferies此前给予该股持有评级及150美元目标价，基本贴近当时股价，未提供明显上行催化；随后公司股价已连续回落，显示合成DNA及AIDD验证服务赛道的短期估值分歧仍在延续。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist盘前走低，投行中性定价分歧延续","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101803817","title":"异动解读｜Twist Bioscience盘中下跌5.44%，合成DNA赛道估值分歧延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1101803817","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101803817?lang=zh_cn&edition=full","pubTime":"2026-10-12 23:26","pubTimestamp":1791818814,"startTime":"0","endTime":"0","summary":"10月12日，Twist Bioscience盘中下跌5.44%，报151.07美元/股，成交额1.14亿美元。消息面上，Jefferies此前启动对Twist Bioscience的覆盖，给予持有评级，目标价150美元，该目标价与当前股价接近，未能提供显著上行催化。此前一日该股已因合成DNA赛道短期估值分歧加大而下跌，今日跌势延续，反映出市场对该赛道估值波动的消化仍在进行。Twist Bioscience Corporation致力于为卫生保健、食品/农业等领域的客户提供合成DNA工具，推动改善生活和地球可持续性的方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience下挫，估值分歧持续发酵","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116939670","title":"异动解读｜Twist Bioscience盘中上涨5.27%，Jefferies持有评级缓解估值分歧","url":"https://stock-news.laohu8.com/highlight/detail?id=1116939670","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116939670?lang=zh_cn&edition=full","pubTime":"2026-10-09 21:38","pubTimestamp":1791553113,"startTime":"0","endTime":"0","summary":"10月9日，Twist Bioscience盘中上涨5.27%，报160.06美元/股，成交额3765.02万美元。消息面上，Jefferies启动对Twist Bioscience的覆盖，给予持有评级，目标价150美元，虽然目标价与当前股价接近、未提供显著上行催化，但缓解了此前因生物科技板块走弱而加剧的短期估值分歧，部分抛压得到释放。此前一日，该股因合成DNA赛道短期估值分歧加大而下跌5.63%，Jefferies的目标价相当于为近期估值波动提供了一个参照锚点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience上涨，Jefferies评级缓解估值分歧","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129923278","title":"异动解读｜Twist Bioscience夜盘上涨5.23%，Jefferies给予持有评级目标价150美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1129923278","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129923278?lang=zh_cn&edition=full","pubTime":"2026-10-09 15:52","pubTimestamp":1791532367,"startTime":"0","endTime":"0","summary":"10月9日，Twist Bioscience夜盘上涨5.23%，报160.0美元/股，成交额215.19万美元。消息面上，Jefferies对Twist Bioscience启动覆盖，给予持有评级，目标价150美元，该目标价与当前股价接近，未提供显著上行催化，但缓解了部分短期估值分歧带来的抛压。此前一日，该股因生物科技板块普遍走弱而下跌5.63%，市场对合成DNA赛道短期估值分歧加大。Twist Bioscience Corporation致力于为那些正在把世界变得更好的客户服务，在卫生保健、食品/农业等领域利用合成DNA工具开发改善方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist夜盘拉升，获机构持有评级","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132843861","title":"异动解读｜Twist Bioscience盘中下跌5.63%，生物科技板块普遍走弱","url":"https://stock-news.laohu8.com/highlight/detail?id=1132843861","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132843861?lang=zh_cn&edition=full","pubTime":"2026-10-08 21:36","pubTimestamp":1791466608,"startTime":"0","endTime":"0","summary":"10月8日，Twist Bioscience盘中下跌5.63%，报146.975美元/股，成交额4771.25万美元。消息面上，Jefferies对Twist Bioscience启动覆盖，给予“持有”评级，目标价150美元，该目标价与当前股价接近，未能提供上行催化。公司此前一日已因板块压力走低，今日跌势延续，反映市场对合成DNA赛道短期估值分歧加大。Twist Bioscience所在的生物科技行业中，个股表现分化，Moderna下跌0.5%，Argenx SE下跌10.69%，艾伯维公司下跌0.39%，Sunshine Biopharma Inc.下跌37.11%，安进下跌1.11%。Twist Bioscience Corporation致力于为那些正在把世界变得更好的客户服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience盘中下跌，生物科技板块承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169425511","title":"异动解读｜Twist Bioscience盘中下跌5.22%，生物科技板块普遍承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1169425511","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169425511?lang=zh_cn&edition=full","pubTime":"2026-10-07 21:30","pubTimestamp":1791379839,"startTime":"0","endTime":"0","summary":"10月7日，Twist Bioscience盘中下跌5.22%，报158.14美元/股，成交额1678.61万美元。该股所在的生物科技行业中，个股表现分化，Moderna下跌7.75%，Natera下跌5.87%，Vaxcyte下跌9.65%，艾伯维上涨0.35%，安进下跌0.09%。Twist Bioscience Corporation致力于为改善世界的客户服务，在卫生保健、食品/农业等领域利用合成DNA工具开发改善方案。公司开发了颠覆性的DNA合成平台，将基于硅的DNA编写技术与专有软件、可伸缩商业基础设施和电子商务平台相结合，推动生物学工程产业化。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118032388","title":"异动解读｜Twist Bioscience盘中上涨5.55%，拟议出售证券引发波动","url":"https://stock-news.laohu8.com/highlight/detail?id=1118032388","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118032388?lang=zh_cn&edition=full","pubTime":"2026-10-05 21:53","pubTimestamp":1791208399,"startTime":"0","endTime":"0","summary":"10月5日，Twist Bioscience盘中上涨5.55%，报199.14美元。消息面上，此前公司公告拟议出售证券，引发市场交易异动。事件背景显示，Twist Bioscience Corp已正式提交144表格报告证券出售计划，该文件通常涉及内部人或大股东减持，可能导致投资者情绪波动。Twist Bioscience Corporation致力于为那些正在把世界变得更好的客户服务，在卫生保健、食品/农业等领域利用合成DNA工具开发改善方案。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114369500","title":"异动解读｜Twist Bioscience盘中上涨5.12%，AI制药卖铲人逻辑延续叠加礼来合作持续催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1114369500","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114369500?lang=zh_cn&edition=full","pubTime":"2026-09-30 23:46","pubTimestamp":1790783196,"startTime":"0","endTime":"0","summary":"9月30日，Twist Bioscience盘中上涨5.12%，报195.66美元/股，成交额2.19亿美元，延续近期强势走势。消息面上，公司9月16日宣布与礼来旗下AI药物发现平台Lilly TuneLab达成抗体表征数据服务合作，承接AI成药性预测验证环节；此前8月，公司被Anthropic选为AI蛋白设计项目的独立评估方，当日股价大涨逾17%。当前AI制药赛道加速升温，Twist凭借硅片DNA合成平台在\"AI设计—湿实验验证\"闭环中的卖铲人定位持续获得资金追捧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AI制药卖铲人强势上涨，礼来合作持续催化","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671210124","title":"Gate 股票永续合约专区上线 TWST 等 6 个合约，CARDS、XDP 合约同步上线","url":"https://stock-news.laohu8.com/highlight/detail?id=2671210124","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671210124?lang=zh_cn&edition=full","pubTime":"2026-09-29 21:40","pubTimestamp":1790689206,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据官方消息，Gate 股票永续合约专区已于 9 月 29 日 20:00（UTC+8）首发上线 TWST（特维斯特生物科技）、CVNA（卡瓦纳）、RUM（拉姆集团）、WBD（华纳兄弟探索）、CRML（关键金属公司）、BWET（破浪油轮航运 ETF）合约交易，并于上线后 1 小时内开放交易机器人及 Order Tracking 功能，支持 1–20 倍做多和做空操作。\n\n同期，Gate 已上线 CARDS（Collector Crypt）及 XDP（Doppler Finance）合约交易、交易机器人及 Order Tracking 功能。其中，CARDS 合约支持 1–10 倍做多和做空操作，XDP 合约支持 1–20 倍做多和做空操作。CARDS 为实体收藏品 RWA 平台；Doppler Finance 致力于打造代币化资本市场基础设施，业务涵盖收益管理、抵押资产效用释放及现实世界资产（RWA）代币化等领域。此次上新进一步丰富 Gate 合约市场的交易标的选择。 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2293029","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","TWST","GNOM","BK4139","WDNA","BK4585","IDNA","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181877804","title":"异动解读｜Twist Bioscience盘中上涨5.35%，AI制药卖铲人逻辑延续叠加礼来合作持续催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1181877804","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181877804?lang=zh_cn&edition=full","pubTime":"2026-09-29 21:38","pubTimestamp":1790689136,"startTime":"0","endTime":"0","summary":"9月29日，Twist Bioscience盘中上涨5.35%，报189.2美元/股，成交额1622.28万美元，延续近期强势走势。消息面上，公司9月16日宣布与礼来旗下AI药物发现平台Lilly TuneLab达成抗体表征数据服务合作，承接AI成药性预测验证环节；此前8月，公司被Anthropic选为AI蛋白设计项目的独立评估方。当前AI制药赛道加速升温，Twist凭借硅片DNA合成平台在\"AI设计—湿实验验证\"闭环中的卖铲人定位持续获得资金追捧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AI制药卖铲人强势上涨，礼来合作催化不断","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151368825","title":"异动解读｜Twist Bioscience夜盘上涨5.17%，AI制药卖铲人逻辑持续发酵叠加礼来合作催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1151368825","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151368825?lang=zh_cn&edition=full","pubTime":"2026-09-28 11:05","pubTimestamp":1790564714,"startTime":"0","endTime":"0","summary":"9月28日，Twist Bioscience夜盘上涨5.17%，报192.29美元/股，成交额23.7万美元，延续近期强势走势。9月16日，Twist宣布与礼来旗下AI药物发现平台Lilly TuneLab达成抗体表征数据服务合作，承接AI成药性预测验证环节；此前8月，公司被Anthropic选为AI蛋白设计项目的独立评估方，当日股价大涨逾17%。当前AI制药赛道加速升温，Twist凭借硅片DNA合成平台在\"AI设计—湿实验验证\"闭环中的卖铲人定位持续获得资金追捧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Twist夜盘大涨，AI制药卖铲人逻辑持续发酵","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155115335","title":"异动解读｜Twist Bioscience盘中上涨5.16%，AI制药订单持续放量叠加礼来合作催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1155115335","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155115335?lang=zh_cn&edition=full","pubTime":"2026-09-24 21:51","pubTimestamp":1790257886,"startTime":"0","endTime":"0","summary":"9月24日，Twist Bioscience盘中上涨5.16%，报166.685美元/股，成交额2768.28万美元，在前一交易日回调后强势反弹。消息面上，公司近期利好密集释放。9月16日，Twist宣布与礼来旗下AI药物发现协作平台Lilly TuneLab达成合作，提供抗体表征数据服务，承接AI成药性预测的验证链条。AI药物发现相关订单从2500万美元翻倍至5000万美元，预计次年达到1亿美元。当前AI制药赛道军备竞赛全面升温，Twist作为\"AI设计-湿实验验证\"闭环中的关键环节持续获得市场关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AI制药订单翻倍，Twist强势上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143449539","title":"异动解读｜Twist Bioscience盘中上涨5.06%，AI制药板块持续走强叠加礼来合作催化延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1143449539","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143449539?lang=zh_cn&edition=full","pubTime":"2026-09-19 03:28","pubTimestamp":1789759724,"startTime":"0","endTime":"0","summary":"9月18日，Twist Bioscience盘中上涨5.06%，报163.43美元/股，成交额2.08亿美元，延续近期强势表现。消息面上，公司近日宣布与礼来旗下AI/ML药物发现平台Lilly TuneLab达成抗体表征数据服务合作，同日金斯瑞、Ginkgo Bioworks亦接入该平台，AI制药产业链从分子设计向湿实验验证环节加速延伸。公司此前在贝尔德全球医疗健康大会上披露，第四财季营收预计约1.24亿美元，同比增长约25%，高于市场一致预期；AI制药相关订单已达5000万美元，预计明年翻番至1亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AI制药催化延续，Twist Bioscience盘中大涨","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132986071","title":"异动解读｜Twist Bioscience盘中上涨6.4%，与礼来TuneLab达成抗体药物发现合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1132986071","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132986071?lang=zh_cn&edition=full","pubTime":"2026-09-17 21:40","pubTimestamp":1789652454,"startTime":"0","endTime":"0","summary":"9月17日，Twist Bioscience盘中上涨6.4%，报153.03美元/股，成交额2543.05万美元。消息面上，公司宣布与礼来旗下AI/ML药物发现平台Lilly TuneLab达成合作，将为其提供抗体表征数据服务，以加速抗体药物发现进程。此外，公司近期在贝尔德全球医疗健康大会上透露，第四财季营收预计约1.24亿美元，同比增长约25%，高于此前市场一致预期的1.174亿美元；AI制药相关订单已达5000万美元，预计明年将翻番至1亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Twist携手礼来TuneLab，AI制药订单加速落地","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152213698","title":"异动解读｜Twist Bioscience盘中上涨5.95%，医疗健康大会更新业绩指引并看好AI制药订单前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1152213698","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152213698?lang=zh_cn&edition=full","pubTime":"2026-09-16 21:32","pubTimestamp":1789565579,"startTime":"0","endTime":"0","summary":"9月16日，Twist Bioscience盘中上涨5.95%，报146.505美元/股，成交额651.18万美元。消息面上，在贝尔德主办的全球医疗健康大会上，公司CEO透露第四财季营收预计约1.24亿美元，同比增长约25%，高于此前FactSet一致预期的1.174亿美元，有望实现连续15个季度营收增长。同时披露AI制药相关订单已达5000万美元，预计明年将翻番至1亿美元。此前公司已被Anthropic选定为AI蛋白质设计项目的独立实验服务商，该消息曾推动股价单日大涨逾17%，自8月以来累计涨超50%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Twist Bioscience盘中上涨，AI制药订单预计翻番","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122936239","title":"异动解读｜Twist Bioscience盘前上涨5.72%，医疗健康大会更新业绩指引并看好AI制药订单前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1122936239","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122936239?lang=zh_cn&edition=full","pubTime":"2026-09-16 20:13","pubTimestamp":1789560793,"startTime":"0","endTime":"0","summary":"9月16日，Twist Bioscience盘前上涨5.72%，报146.0美元/股，成交额11.2万美元。消息面上，在贝尔德主办的全球医疗健康大会上，公司CEO透露第四财季营收预计约1.24亿美元，同比增长约25%，即连续15个季度实现营收增长；同时披露当前AI制药相关订单已达5000万美元，预计明年将翻番至1亿美元。此前公司已被Anthropic选定为AI蛋白质设计项目的独立实验服务商，自8月以来股价累计涨超50%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Twist Bioscience盘前上涨，AI制药订单有望翻番","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175985719","title":"异动解读｜Twist Bioscience盘中上涨6.12%，报135.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175985719","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175985719?lang=zh_cn&edition=full","pubTime":"2026-09-15 00:19","pubTimestamp":1789402791,"startTime":"0","endTime":"0","summary":"9月14日，Twist Bioscience盘中上涨6.12%，报135.04美元/股，成交额1.01亿美元。Twist Bioscience所在的生物科技行业中，个股中，Moderna涨1.83%，艾伯维公司涨1.91%，安进涨0.75%，吉利德科学涨1.32%，再生元制药公司涨1.20%。Twist Bioscience于特拉华州注册成立，致力于利用其颠覆性的DNA合成平台为客户提供合成DNA工具，业务覆盖卫生保健、食品/农业、工业化学品、学术研究及数据存储等领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.twistbioscience.com","stockEarnings":[{"period":"1week","weight":-0.0796},{"period":"1month","weight":-0.163},{"period":"3month","weight":0.4581},{"period":"6month","weight":1.2116},{"period":"1year","weight":3.9634},{"period":"ytd","weight":3.4064}],"compareEarnings":[{"period":"1week","weight":-0.0149},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.0243},{"period":"6month","weight":0.0777},{"period":"1year","weight":0.1537},{"period":"ytd","weight":0.124}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Twist Bioscience Corporation于2013年2月4日在特拉华州注册成立。该公司致力于为那些正在把世界变得更好的客户服务。在卫生保健、食品/农业、工业化学品、学术研究和数据存储等领域，客户正在利用他们的合成DNA工具开发改善生活和改善地球可持续性的方法。他们开发了一个颠覆性的DNA合成平台，使生物学工程产业化，为广泛的用途和市场提供DNA。他们将基于硅的DNA编写技术与专有软件、可伸缩的商业基础设施和电子商务平台结合起来，创建了一个集成的技术平台。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.077829},{"month":2,"riseRate":0.375,"avgChangeRate":-0.03419},{"month":3,"riseRate":0.375,"avgChangeRate":-0.060203},{"month":4,"riseRate":0.5,"avgChangeRate":-0.03729},{"month":5,"riseRate":0.75,"avgChangeRate":0.086916},{"month":6,"riseRate":1,"avgChangeRate":0.238398},{"month":7,"riseRate":0.625,"avgChangeRate":0.087317},{"month":8,"riseRate":0.25,"avgChangeRate":-0.006755},{"month":9,"riseRate":0.5,"avgChangeRate":0.016501},{"month":10,"riseRate":0.375,"avgChangeRate":-0.048524},{"month":11,"riseRate":0.625,"avgChangeRate":0.212894},{"month":12,"riseRate":0.25,"avgChangeRate":0.020968}],"exchange":"NASDAQ","name":"Twist Bioscience Corp","nameEN":"Twist Bioscience Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Twist Bioscience Corp(TWST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Twist Bioscience Corp(TWST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Twist Bioscience Corp,TWST,Twist Bioscience Corp股票,Twist Bioscience Corp股票老虎,Twist Bioscience Corp股票老虎国际,Twist Bioscience Corp行情,Twist Bioscience Corp股票行情,Twist Bioscience Corp股价,Twist Bioscience Corp股市,Twist Bioscience Corp股票价格,Twist Bioscience Corp股票交易,Twist Bioscience Corp股票购买,Twist Bioscience Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Twist Bioscience Corp(TWST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Twist Bioscience Corp(TWST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}